Whittier Trust CO Arrowhead Pharmaceuticals, Inc. Transaction History

Whittier Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$27.79 - $50.61 $1,222 - $2,226	-44 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$39.62 - $69.97 $1,743 - $3,078	44 New	44 $2,000
Q4 2021 Jan 19, 2022	SELL	$58.09 - $82.51 $29,045 - $41,255	-500 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$58.38 - $84.96 $11,676 - $16,992	-200 Reduced 28.57%	500 $31,000
Q4 2020 Jan 29, 2021	BUY	$43.82 - $85.37 $21,910 - $42,685	500 Added 250.0%	700 $54,000

Q3 2020 Oct 30, 2020	BUY	$33.21 - $51.27 $6,642 - $10,254	200 New	200 $9,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.